Event Details
July 24, 2015
Description
The FDA approved Praluent, a new cholesterol-lowering injectable drug developed by Regeneron Pharmaceuticals.
Source Documents (1)
HOUSE_OVERSIGHT_026362.jpg
Email
• 1.27 MB
This document is an email from Jeffrey Epstein to Sultan Bin Sulayem on July 24, 2015, discussing a new, expensive cholesterol-lowering drug called Praluent. Epstein's email is a reply to an inquiry from Sulayem, who had forwarded a Forbes article announcing the FDA's approval of the drug, which is administered as a shot.
Event Metadata
Type
Unknown
Location
United States
Significance Score
5/10
Participants
0
Source Documents
1
Extracted
2025-11-19 05:18
Additional Data
Source
HOUSE_OVERSIGHT_026362.jpg
Date String
2015-07-24
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event